The independent source for health policy research, polling, and news.
KFF’s policy research provides facts and analysis on a wide range of policy issues and public programs.
KFF designs, conducts and analyzes original public opinion and survey research on Americans’ attitudes, knowledge, and experiences with the health care system to help amplify the public’s voice in major national debates.
KFF Health News is a national newsroom that produces in-depth journalism about health issues and is one of the organization’s core operating programs.
This brief looks at newly announced changes by HHS to the pediatric vaccination schedule, which reduce the number of vaccines recommended for all children. Implications of these changes for childhood vaccination rates and trust in public health are discussed.
A new KFF analysis examines key characteristics of children with special health care needs, the affordability and adequacy of their health coverage, and the implications for such children of potential new federal Medicaid money to assist families in caring for them.
This brief highlights key issues to consider for the vaccination rollout to younger children.
This report tracks the public's COVID-19 vaccine intentions, including parents' intentions for their children ages 5-11 who may soon become eligible to get a vaccine. It also examines workers' experiences with and views toward employer vaccine mandates and the public's holiday plans heading into the second holiday season under the pandemic.
In this Axios column, Drew Altman examines the data about what parents say they will do once their children ages 5-11 become eligible for a COVID-19 vaccine, and why it will take some time and a concerted outreach effort to match adult vaccination rates.
This brief examines characteristics of uninsured children in 2020 and discusses how current policy proposals, including outreach efforts, continuous eligibility requirements, and closing the coverage gap, could affect children’s health coverage. Recent efforts to expand coverage for adults could benefit children’s coverage, especially for children in non-expansion states if the coverage gap is filled as proposed by the Build Back Better Act (BBBA).
Following the recent US Food & Drug Administration’s (FDA) authorization and the Centers for Disease Control and Prevention’s (CDC) recommendation, children ages 5-11 are now eligible to receive Pfizer-BioNTech’s COVID-19 vaccine. There may be unique challenges to vaccinating young children, particularly those from low-income families who may face additional barriers to access. State Medicaid programs and Medicaid managed care plans are looking at a range of policy options to facilitate access to vaccines for young, low-income children.
Major federal changes to Medicaid and other health-related policies could impact children’s health in the coming years. This issue brief explores the latest data on Medicaid and children’s health and highlights five key issues to watch as those federal changes are implemented.
Weeks after the Trump administration reduced the number of childhood vaccine recommended for routine use, public trust in the CDC is at its lowest since the COVID-19 pandemic, and less than half are confident in federal agencies' ability to make such recommendations. Among those who have heard about the revised recommendations, more say they expect the changes to have a negative impact than a positive one on children’s health.
This volume highlights how a report criticized for flawed methodology is influencing renewed efforts to restrict access to mifepristone; a federal plan to study the causes of autism that could be contributing to stigma by over-emphasizing environmental toxins; and the resurgence of false claims about fetal tissue in vaccines.
© 2026 KFF